These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1306363)

  • 1. Anti-infectious effect of C granulosum-derived P40 immunomodulator given by aerosolization and intranasal instillation.
    Bizzini B; Carlotti M; Fattal German M
    Biomed Pharmacother; 1992; 46(10):491-4. PubMed ID: 1306363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Corynebacterium granulosum-derived P40 immunomodulator exerts a synergistic effect on the activity of antiviral drugs in the treatment of experimental viral infections.
    Fattal-German M; Bizzini B
    Biomed Pharmacother; 1988; 42(3):217-20. PubMed ID: 3179407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The restoration of impaired macrophage functions using as immunomodulator the Corynebacterium granulosum-derived P40 fraction.
    Mastroeni P; Bizzini B; Bonina L; Iannello D; Merendino RA; Delfino D; Berlinghieri MC; Leonardi MS; Arena A; Liberto MC
    Immunopharmacology; 1985 Aug; 10(1):27-34. PubMed ID: 2997082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of various cytokines in mice and activation of the complement system in rats as a part of the mechanism of action of the Corynebacterium granulosum-derived P40 immunomodulator.
    Bizzini B; Carlotti M; Fattal-German M
    FEMS Microbiol Immunol; 1992 Oct; 5(4):171-80. PubMed ID: 1384603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiating the effectiveness of influenza vaccination by a combined immunostimulation with P40 immunomodulator: an experimental study in mice.
    Fattal-German M; German A; Bizzini B
    Biomed Pharmacother; 1988; 42(1):73-8. PubMed ID: 3408809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental and clinical results with the Corynebacterium granulosum-derived immunomodulator P40.
    Bizzini B; Henocq E; Reynier J; Relyveld EH
    Asian Pac J Allergy Immunol; 1984 Jun; 2(1):144-53. PubMed ID: 6529476
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunomodulation with P40, an insoluble delipidated fraction of Corynebacterium granulosum. II.--Specific immune responses of the host.
    Lagrange PH; Fuster MJ
    Ann Immunol (Paris); 1982; 133C(3):269-87. PubMed ID: 7149643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of nasal mucosa-associated antigen-presenting cells in vivo with an outer membrane protein A derived from Klebsiella pneumoniae.
    Goetsch L; Gonzalez A; Plotnicky-Gilquin H; Haeuw JF; Aubry JP; Beck A; Bonnefoy JY; Corvaïa N
    Infect Immun; 2001 Oct; 69(10):6434-44. PubMed ID: 11553588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteliposome-derived Cochleate as an immunomodulator for nasal vaccine.
    Pérez O; Bracho G; Lastre M; Zayas C; González D; Gil D; del Campo J; Acevedo R; Taboada C; Rodríguez T; Fajardo ME; Sierra G; Campa C; Mora N; Barberá R; Solís RL
    Vaccine; 2006 Apr; 24 Suppl 2():S2-52-3. PubMed ID: 16823925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of an immunomodulator (P40) on Escherichia coli urinary infection in the rat].
    Mathieu D; Fries D; Auer J; Bizzini B; Jacques L
    Biomed Pharmacother; 1982; 36(10):420-5. PubMed ID: 6764138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannan adjuvants intranasally administered inactivated influenza virus in mice rendering low doses inductive of strong serum IgG and IgA in the lung.
    Proudfoot O; Esparon S; Tang CK; Laurie K; Barr I; Pietersz G
    BMC Infect Dis; 2015 Feb; 15():101. PubMed ID: 25887952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation by nonspecific immunostimulation of the efficacy of antibiotics in the treatment of experimental bacterial infections.
    Bizzini B; Fattal-German M
    Biomed Pharmacother; 1989; 43(10):753-61. PubMed ID: 2534887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced resistance of mice against influenza virus infection after local administration of glycoprotein extracts from Klebsiella pneumoniae.
    Rudent A; Zalisz R; Quero AM; Smets P
    Int J Immunopharmacol; 1985; 7(4):525-31. PubMed ID: 2412973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary experimental and clinical results with inactivated allergens conjugated to the Corynebacterium granulosum-derived immunomodulator P40.
    Henocq E; Prouvost-Danon A; Bizzini B
    Boll Ist Sieroter Milan; 1987; 66(1):70-7. PubMed ID: 3620123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of L1210 mouse leukemia by immunization with xenogenized tumor cells combined with immunostimulation by the P40 fraction of C. granulosum and chemotherapy.
    Relyveld EH; Bizzini B; Ben-Efraim S
    Int J Immunopharmacol; 1984; 6(5):445-50. PubMed ID: 6500782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological evaluation of bacterial derived Cochleate and proteoliposome as mucosal adjuvants.
    del Campo J; Lastre M; Bracho G; Rodríguez T; Gil D; Zayas C; Taboada C; Acevedo R; Pérez DR; Pérez O
    Vaccine; 2006 Apr; 24 Suppl 2():S2-50-1. PubMed ID: 16823924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines.
    Wu H; Bao Y; Wang X; Zhou D; Wu W
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-9. PubMed ID: 28129034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant.
    Ichinohe T; Watanabe I; Tao E; Ito S; Kawaguchi A; Tamura S; Takahashi H; Sawa H; Moriyama M; Chiba J; Komase K; Suzuki Y; Kurata T; Sata T; Hasegawa H
    J Med Virol; 2006 Jul; 78(7):954-63. PubMed ID: 16721854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onjisaponins, from the root of Polygala tenuifolia Willdenow, as effective adjuvants for nasal influenza and diphtheria-pertussis-tetanus vaccines.
    Nagai T; Suzuki Y; Kiyohara H; Susa E; Kato T; Nagamine T; Hagiwara Y; Tamura S; Yabe T; Aizawa C; Yamada H
    Vaccine; 2001 Sep; 19(32):4824-34. PubMed ID: 11535335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Eurocine L3 adjuvants with subunit influenza antigens induce protective immunity in mice after intranasal vaccination.
    Petersson P; Hedenskog M; Alves D; Brytting M; Schröder U; Linde A; Lundkvist A
    Vaccine; 2010 Sep; 28(39):6491-7. PubMed ID: 20637767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.